Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy

BACKGROUND: Most thalassemic patients with chronic hepatitis C virus (HCV) infection do not respond to therapy with pegylated interferon (Peg-IFN) plus ribavirin (RBV) due to hepatic siderosis and RBV dose reduction caused by RBV-induced anemia. OBJECTIVES: In the present study, we recruited HCV gen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepat Mon
Main Authors: Sandoughdaran, Saleh, Alavian, Seyed Moayed, Sharafi, Heidar, Behnava, Bita, Salimi, Shima, Mehrnoush, Leila, Karimi Elizee, Pegah, Keshvari, Maryam
Formato: Artigo
Idioma:Inglês
Publicado em: Kowsar 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4344648/
https://ncbi.nlm.nih.gov/pubmed/25741371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.23564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados